nitarsone has been researched along with Alzheimer Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayraktar, G; Friese, MA; Goldschmidt, J; Gomes, GM; Grochowska, KM; Kaneko, H; Karpova, A; Kaushik, R; Kreutz, MR; Morawski, M; Navarro, G; Oelschlegel, AM; Raman, R; Reissner, C; Remy, S; Reyes-Resina, I; Rossner, S; Samer, S; Sosulina, L; Spilker, C; Woo, MS; Yuanxiang, P | 1 |
1 other study(ies) available for nitarsone and Alzheimer Disease
| Article | Year |
|---|---|
Jacob-induced transcriptional inactivation of CREB promotes Aβ-induced synapse loss in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Mice; Mice, Transgenic; Neurons; Synapses | 2023 |